AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)

OB GYN News

| September 15, 2004 | Hayman, Mark; Calfee, John E. | COPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

YES

If incorporated appropriately, the review of economic factors by the Food and Drug Administration could help facilitate a new drug's entrance into the market.

A new drug isn't going to get far in the marketplace if managed care organizations and other payers are unwilling to cover it. And these payers want to see cost-effectiveness data. The problem is that cost-effectiveness claims are difficult and time consuming to evaluate.

If payers had an independent evaluation of cost-effectiveness from the FDA, it could make coverage decisions easier and faster--allowing cost-effective drugs a smooth path to the marketplace.

Economic data could be collected by drug companies during phase III drug trials and forwarded to the FDA as part of a new drug application (NDA).

The FDA already has some experience in evaluating cost-effectiveness claims. For example, the agency evaluates the promotional material for drugs on the market, and at least some of that review involves evaluation of cost-effectiveness claims.

It isn't a big stretch to think that the FDA could do that type of review earlier, during review of an NDA.

Related articles from newspapers, magazines, journals, and more
Expert in Pharmaceutical Sciences and New Drug Applications to FDA Joins...
Press release article from: Business Wire February 21, 2007 700+ words
...applications and abbreviated new drug applications to the FDA," explained Mr...an Investigational New Drug application with the FDA for our type-2 diabetes...applications to the FDA, including Investigational New Drug, New Drug Application...
FDA unveils new drug-safety rules.(Food and Drug Administration)
News wire article from: Philadelphia Inquirer (Philadelphia, PA) May 21, 2005 700+ words
...Drug Administration unveiled new drug-safety rules yesterday aimed...influence of drugmakers on certain FDA actions. Steven K. Galson...journalists, in which he and other FDA officials reviewed the FDA's new drug-safety initiatives. Drug...
FDA Extends New Drug Application -- NDA -- Action Date for EPIX's MS-325 to...
News wire article from: The America's Intelligence Wire October 4, 2004 700+ words
...covering all aspects of the new drug application. At the FDA's request, we have provided...review questions made by the FDA. In its review process for any new drug, including, of course, MS-325, the FDA will challenge the efficacy...
Independence of FDA's new drug safety board questioned.(News)
Magazine article from: Family Practice News Silverman, Jennifer March 15, 2005 700+ words
...recommendations and concerns of the FDA's current Office of...ignored by the agency's new drug reviewers. If the new...next few months," an FDA spokeswoman said. As...oversight initiative, FDA plans to create a new "Drug Watch" Web page, a...
FDA Extends New Drug Application -- NDA -- Action Date for EPIX's MS-325 to...
News wire article from: Fair Disclosure Wire October 4, 2004 700+ words
...covering all aspects of the new drug application. At the FDA's request, we have provided...review questions made by the FDA. In its review process for any new drug, including, of course, MS-325, the FDA will challenge the efficacy...
CORRECTION: FDA places hold on Andrx's new drug applications.
News wire article from: Miami Herald (Miami, FL) September 7, 2005 700+ words
...the story slugged MI-ANDRX-FDA, filed by Knight Ridder/Tribune...is operating. The company's new drug applications have been put on...the following corrected one. FDA places hold on Andrx's new drug applications By John Dorschner...
FDA's new drug safety board under scrutiny.(Practice Trends)
Magazine article from: OB GYN News Silverman, Jennifer March 1, 2005 700+ words
...recommendations and concerns of the FDA's current Office of...ignored by the agency's new drug reviewers. If the new...next few months," an FDA spokeswoman said. As...oversight initiative, FDA plans to create a new "Drug Watch" Web page, a...
8th Edition of "New Drug Development: A Regulatory Overview" Assesses How the...
Press release article from: M2 Presswire March 6, 2008 700+ words
...8th Edition of "New Drug Development: A Regulatory...Assesses How the FDA Amendments Act of...their offering. New Drug Development: A Regulatory...drug development and FDA regulatory process...date analysis of FDA's new drug development process...
FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum...
Press release article from: PR Newswire September 13, 2007 700+ words
- FDA Targets January 11...the amendment to the New Drug Application (NDA...that our existing and new drug candidates may not receive approval from the FDA, and other regulatory...that our existing and new drug candidates, if approved...
FDA review may cut into thyroxine supply. (Action on New Drug...
Magazine article from: Family Practice News Moon, Mary Ann February 1, 2002 700+ words
...manufacturer to file a New Drug Application for each...Laboratories petitioned the FDA to "grandfather...spare it from the New Drug Approval process...review process. The FDA will make an announcement...only if and when the New Drug Applications are approved...
For more facts and information, see all results

Source: HighBeam Research, Should the FDA consider cost-effectiveness when approving new drug...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA